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Abstract
Aim The aims of this study were to examine the requests for influenza molecular tests processed by the Virology Laboratory of
the University Hospital of Udine during the 2018–19 influenza season and to assess the test results and to estimate costs.
Subjects and methods We analyzed various administrative databases of the hospital health information system, which can be
deterministically linked at the individual level through an anonymous stochastic key. Requests for influenza molecular tests from
November 1, 2018, to April 15, 2019, and test results were described by week and, for hospitalized patients, hospital ward.
Previous vaccination status of tested patients, outcomes and estimated test costs were assessed.
Results In the 2018–19 influenza season, 979 influenza A and B virologic tests were processed by the laboratory, corresponding
to 758 patients. Requests had more than doubled compared with the previous influenza season. Rapid real-time PCR tests,
routinely available at the University Hospital of Udine since January 2019, represented 17% of requests. Six hundred forty-eight
patients were hospitalized. Medical wards requested the test after a median of 1 day after admission, whereas requests were
delayed for surgical and oncologic patients. The number of tests, proportion of positivity and consumption of rapid tests varied by
medical specialty. Overall consumption of oseltamivir was similar to that of the previous influenza season.
Conclusions This analysis, benefiting from the availability of integrated health administrative databases, provided useful infor-
mation to support public health decision-making and managing the supply and demand for diagnostic tests.
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Introduction
Laboratory diagnosis of influenza is important for several rea-
sons. The laboratory can isolate circulating viruses and con-
tribute to vaccine development; in addition, thanks to the abil-
ity to differentiate virus subtypes with similar clinical presen-
tation, it has a role in disease surveillance and treatment of
illness. In the hospital setting, where the treatment aim is pre-
dominant, prompt and accurate diagnosis supports clinical
decisions regarding infection control measures and antimicro-
bial therapy.
In the Italian Northeastern Region Friuli Venezia Giulia,
clinical recommendations for the management of hospitalized
patients with influenza-like syndromes (Regione autonoma
Friuli Venezia Giulia 2019) require that biological samples
are collected from patients with serious or complicated illness
within 3–4 days from the start of symptoms and that they are
sent to a reference laboratory for influenza confirmation,
subtyping and mutation detection. However, the decision re-
garding whether to initiate antiviral therapy is based only on
clinical severity of illness and individual risk factors, accord-
ing to the guide issued by the Centers for Disease Control and
Prevention (CDC 2019). Nonetheless, as the CDC remarks,
hospitalized patients with suspected influenza should be tested
with molecular assays with high sensitivity and specificity
(such as real-time PCR) to inform decisions on antiviral ther-
apy and to prevent nosocomial outbreaks through prompt im-
plementation of control measures (CDC 2019).
The Italian integrated epidemiologic and virologic influen-
za surveillance system InfluNet showed that, after one of the
highest peaks of the past 15 years registered in the 2017–18
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season, the incidence of influenza-like syndromes in the
2018–19 season was slightly lower than in the previous year
(InfluNet 2019).
In the University Hospital of Udine, a tertiary 1000-bed
academic hospital located within the Friuli Venezia Giulia
region, influenza virus testing through molecular assays can
be requested of the Virology Laboratory, where, since January
2019, two rapid molecular assays, with test time < 30 min,
have been available in addition to multiplex molecular assays,
with test time of hours. According to the hospital's internal
procedures, rapid assays should be requested for hospitalized
patients only upon an infectious disease consult.
The principal objectives of this study were to examine the
requests of influenza molecular tests processed by the
Virology Laboratory of the University Hospital of Udine dur-
ing the 2018–19 influenza season to assess test results and to
estimate costs.
Methods
We used the administrative databases of the Health
Information System of the Local Health Authority of Udine
as the source of information. Databases are anonymous (pa-
tients cannot be identified); however, they can be linked with
each other at the individual patient level through a univocal
stochastic key.
For this study, we analyzed the laboratory database, which
includes requests and results of all laboratory tests conducted
at the University Hospital of Udine, located in the territory
served by the Local Health Authority of Udine, the hospital
discharge database, the hospital drug consumption database
and the vaccination database of the Local Health Authority of
Udine.
We analyzed all the influenza A and B molecular diagnos-
tic tests performed by the Virology Laboratory of the Hospital
betweenNovember 1, 2018, and April 15, 2019. The available
tests are:
– Allplex™ Respiratory Panel 1 (Seegene, Republic of
Korea), a one-step real-time PCR assay for influenza A
virus, influenza B virus, respiratory syncytial virus A,
respiratory syncytial virus B, influenza A-H1, influenza
A-H1pdm0, influenza A-H3 on nasopharyngeal swab,
nasopharyngeal aspirate or bronchoalveolar lavage, avail-
able throughout the entire 2018–19 season as well as in
the previous year;
– Xpert®Flu (Cepheid, USA), a rapid real-time PCR assay
for influenza A, B and H1N1 on nasal aspirate/washes or
nasopharyngeal, routinely available in Udine since
January 2019;
– Xpert® Xpress Flu/RSV (Cepheid, USA), a rapid real-
time PCR assay for influenza A and B and respiratory
syncytial virus on nasal aspirate/washes or nasopharyn-
geal, routinely available in Udine since January 2019.
Two additional multiplex tests for respiratory infections,
not including influenza virus, but often requested at the same
time, are:
– Allplex™ Respiratory Panel 2 (Seegene, Republic of
Korea), for adenovirus, enterovirus, metapneumovirus,
parainfluenza virus 1, parainfluenza virus 2 and
parainfluenza virus 3;
– Allplex™ Respiratory Panel 3 (Seegene, Republic of
Korea), for bocavirus 1/2/3/4, coronavirus 229E, corona-
virus NL63, coronavirus OC43 and rhinovirus.
We assessed the frequency of tests requested in each week
of the study period, of patients with at least one influenza test
and of patients with at least one positive test in the season.
For tests requested for patients admitted to the hospital,
with sampling date between admission and discharge dates,
we described the specialty of the ward where the patient was
hospitalized, timing of the request, main discharge diagnoses
and hospitalization outcome.
In all patients with influenza tests, we assessed whether
they had been vaccinated at least 14 days before the influenza
test sampling. Differences in the frequency of vaccinated pa-
tients in the group with negative test results and those with
positive results were assessed through the chi-square test. The
statistical significance of differences in continuous numerical
variables was assessed using the t-test in case of variables with
a normal distribution and Wilcoxon’s rank sums test other-
wise. Normality was checked using the Kolmogorov-
Smirnov test. P values < 0.05 were considered statistically
significant.
We compared the number of test requests and estimated
costs in the 2018–19 season with those in the 2017–18 season,
when the rapid test was not routinely available in Udine. The
number of doses of the antiviral drug oseltamivir (ATC code
J05AH02) distributed to the wards by the hospital pharmacy
during the two influenza seasons was also described.
All the analyses were conducted using SAS v7.15 (SAS
Institute Inc., Cary, NC, USA).
Ethical considerations
All procedures contributing to this work comply with the eth-
ical standards of the relevant national and institutional com-
mittees on human experimentation and with the Declaration of
Helsinki. The analyses were based on anonymous administra-
tive data; therefore, patient informed consent and ethics com-
mittee approval were not required in Italy. Patients were not
identifiable, and their privacy rights were always observed.
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Results
During the 2018–19 influenza season, 979 influenza A and B
virologic tests were processed by the Virology Laboratory of
the University Hospital of Udine, corresponding to 758 pa-
tients. Of them, 618 (81.5%) had only one test request during
the season whereas the others had two or more (up to 5).
Overall, 814 traditional tests and 165 rapid tests were
conducted.
Eight hundred nine requests (82.6%) were related to 648
inpatients hospitalized at the University Hospital of Udine.
The trends of influenza virus test requests among inpatients
are shown in Fig. 1. Traditional tests outnumbered rapid tests;
from week 3 to week 8 of 2019, rapid molecular assays rep-
resented > 20% of all requests. Overall, the peak of requests
was from week 4 to week 9 of 2019.
Thirty-two hospital wards requested at least one influenza
virus test during the 2018–19 season. Specialties with the
highest number of requests were internal medicine (3 wards,
overall 28.7% of all tests), infectious diseases (13.7% of all
tests), pneumology (11.7%), hematology (9.5%), pediatrics
(8.7%), intensive care units (3 wards, 5.7%) and oncology
(4.2%), accounting for > 80% of all requests. Rapid tests were
requested by 19 wards. Figure 2 shows the proportion of rapid
tests for specialties requesting ≥ 10 tests. The average number
of test requests per hospitalized patient ranged from values
close to 1 for emergency medicine, nephrology, pediatrics
and neonatology to values > 1.5 for cardiac surgery, ICU
and general surgery.
Overall, median time from admission to testing was 1 day
(25th percentile 1 day, 75th percentile 6). Median time from
admission to testing ranged from 1 day in most medical spe-
cialties (internal medicine, cardiology, rheumatology, emer-
gency medicine, infectious diseases, neonatology, pediatrics,
pneumology) to 5–8 days in most surgical specialties (except
obstetrics and gynecology, 1 day) to more than 1 week for
onco-hematology. In seven hospitalizations with length of
stay > 1 day, the test was requested for the first time on the
same day as the patient’s discharge.
None of the 648 tested inpatients were positive for influen-
za B virus; 114 (17.2%) were positive for influenza A virus.
Positivity for influenza A virus among inpatients is shown in
Fig. 3. Positivity started in the first week of 2019 and ended at
week 12. The proportion of influenza-A positivity by specialty
is shown in Fig. 4.
Of the 758 patients who underwent influenza A virologic
tests in the 2018–19 season, 188 (24.8%) had been vaccinated
against influenza at least 14 days before being tested. Tests
Fig. 1 Requests for influenza virus tests from November 1, 2018, to April 15, 2019, among patients hospitalized at the University Hospital of Udine,
Italy
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were positive in 18.8% of unvaccinated and 21.3% of vacci-
nated patients (p = 0.4513). After stratifying by age (< 65 vs. ≥
65 years), positivity was almost identical in unvaccinated and
vaccinated subjects (16.4% vs. 15.6%, p = 0.8818, in the
younger group and 22.4% vs. 23.1%, p = 0.8838, in the elder-
ly). Among influenza A-positive inpatients, 28 (24.6%) were
assigned a main discharge diagnosis of influenza (ICD-9-CM
487.x). Thirteen influenza A-positive inpatients (11.4%) died
during the hospitalization; in-hospital crude mortality among
influenza A-negative inpatients was 10.1%. Length of stay
was similar in influenza-A-positive and -negative patients
(mean 15.8 ± 12.3, median 12 days, mean 18.9 ± 21.5, median
11, respectively; p value of Wilcoxon’s rank sums test
0.7260).
In the 2017–18 season, overall requests for influenza A and
B virus tests at the University Hospital of Udine were 426 in
375 patients; 4.5% of tests were positive for influenza A virus
and 9.9% for influenza B. In the 2017–18 season, all wards
requested fewer tests than in 2018–19, except pediatrics (77
requests in 2017–18 vs. 70 in 2018–19).
The estimated cost of diagnostic tests, assuming conserva-
tively to have used 9 multiplex panel 100-test kits (with a 70–
75% yield) and 17 rapid 10-test kits in the 2018–19 season
and 5multiplex panel 100-test kits in the 2017–18 season, was
14,127 euros in 2018–19 and 4165 euros in 2017–18. The cost
per detected case was 77.6 euros and 68.3 euros, respectively.
In the 2018–19 season, 1815 doses of oseltamivir were
distributed to the wards by the hospital pharmacy (10 in
November, 72 in December, 861 in January, 434 in
February, 355 in March and 83 in the first half of April). In
the corresponding period of the 2017–18 season, doses were
1616. Consumption of oseltamivir by medical specialty is
shown in Table 1.
Discussion
Main finding of this study
This study described the requests for molecular diagnostic
tests for influenza virus processed by the Virology
Laboratory of the Italian 1000-bed University Hospital of
Udine during the 2018–19 influenza season, when two rapid
real-time PCR assays were made available in addition to stan-
dard multiplex real-time PCR assays.
In the 2018–19 season, although in Italy the incidence of
influenza-like syndromes was similar to that of the previous
season (InfluNet 2019), the number of influenza test requests
Fig. 2 Number of influenza virus tests and proportion of rapid molecular assays among patients admitted to the University Hospital of Udine, Italy,
during the 2018–19 influenza season, by medical specialty
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in Udine doubled (with a similar proportion of positivity). The
arrival and availability of rapid PCR tests, which was an-
nounced and presented to all the hospital wards through offi-
cial communications from the hospital management, brought
attention to the issue of influenza virology diagnostics and
might have induced an increase of requests, both of new rapid
PCR tests and the standard ones.
Our data suggest the inappropriateness of some requests.
For example, multiple requests for the same hospitalized pa-
tient were likely unnecessary. There was also evidence of tests
requested on the patient’s discharge date. In addition, some
wards showed high numbers of test requests but low propor-
tions of positive results, suggesting that requests were not
focused. Unfocused test requests, instead of supporting clini-
cal decisions, might paradoxically divert attention from clini-
cal presentation, which is important for deciding whether an-
tiviral therapy should be initiated (CDC 2019).
What is already known on this topic
Rapid PCR testing can improve the management and out-
comes of hospitalized patients with respiratory illnesses. In
an Australian study, for example, rapid PCR testing reduced
length of stay among those who tested positive and resource
utilization, regardless of positivity, and improved timeliness
of care compared with standard PCR testing (Wabe et al.
2019). Our analysis cannot assess the advantages of rapid
PCR tests vs. other types of testing or not testing at all, since
this was an observational study with only descriptive pur-
poses. However, the collected data were useful for organiza-
tional purposes and to identify potential sources of
inappropriateness.
In Hong Kong, empirical antiviral treatment appeared to be
a cost-effective strategy vs. test-guided treatment in the man-
agement of hospitalized patients with severe respiratory infec-
tion with a suspect of influenza, at least in case of influenza
prevalence ≥ 2.5% (You et al. 2012). Thus, limiting urgent
requests for rapid tests in patients with mild uncomplicated
illness during the influenza season might be appropriate.
What this study adds
In our hospital, the highest proportions of rapid PCR test re-
quests were among patients hospitalized in the emergency
medicine ward and in the infectious diseases ward, where
patients with severe or complicated illness are more likely to
be found.
Requests were usually timely for patients hospitalized in
medical wards (median time 1 day after admission), whereas
there was greater delay in surgical wards (up to 1 week),
Fig. 3 Proportion of tested inpatients positive for influenza A virus by week, University Hospital of Udine, Italy, influenza season 2018–19
J Public Health (Berl.): From Theory to Practice
where cases of respiratory illness might be the result of
hospital-acquired infections (Chow and Mermel 2017;
Haque et al. 2018). Onco-hematologic patients were tested
even later, but this is expected since these patients are not
usually admitted for a respiratory infection and have high risk
of hospital-acquired infection (Guinan et al. 2003).
In our hospital, patients with previous vaccination against
influenza were also tested. We do not know whether the pa-
tients’ vaccination status was known to the attending physi-
cians. Anyway, the proportion of positivity among tested pa-
tients was analogous regardless of vaccination status, indicat-
ing that previous vaccination is not sufficient to rule out
Fig. 4 Proportion of tested inpatients positive for influenza A virus by specialty of hospitalization, University Hospital of Udine, Italy, influenza season
2018–19
Table 1 Consumption of
oseltamivir doses during the
influenza seasons 2017–18 and
2018–19 by medial specialty at
the University Hospital of Udine,
Italy
Oseltamivir doses 2018–19 Oseltamivir doses 2017–18
ICU 188 671
Post-acute care 10 10
Cardiology 20 20
Surgery (any) 12 122
Hematology 20 30
Infectious diseases 341 240
Internal medicine 526 140
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influenza infection. It should be noted that our findings do not
support the conclusion that vaccination was ineffective. In
fact, analyzing our data according to a test-negative design
would have yielded valid results only if vaccination status
had not affected the probability of being hospitalized, if there
was no confounding (Fukushima and Hirota 2017; Shi et al.
2017) and if every hospitalized patient with acute respiratory
illness was tested (Ainslie et al. 2017), conditions that were
not fulfilled in our analysis.
Direct cost of one rapid real-time PCR test was approxi-
mately 39 euros; estimated cost of one Panel 1 multiplex test,
considering a 70–75% yield, was almost 12 euros. In case of
unfocused requests for respiratory viruses (i.e., all 3 multiplex
panels) the cost is almost 36 euros per request, very close to
the cost of one rapid test. Thus, for the upcoming influenza
season, we will promote requesting rapid real-time PCR tests
for all cases of serious or complicated respiratory illness, lim-
iting multiplex tests to well-defined diagnostic suspicions.
The new hospital-based recommendations for requesting in-
fluenza virus tests will also have to address areas of potential
inappropriateness detected in the past influenza season.
The analysis of local laboratory data, improving the knowl-
edge and evidence base around diagnostics, provides useful
information to support public health decision-making and
manage diagnostic demand and supply (Engel et al. 2016).
A study from six European countries showed that availability
of laboratory resources may induce inappropriate demand for
laboratory tests (Mrazek et al. 2020). This was at least partly
true in our case, too. In agreement with the authors of that
study, we believe that communication between laboratory
specialists and clinicians should be intensified and improved.
Educational interventions may also be useful to reduce inap-
propriate requests. Another strategy that could influence the
clinicians’ ordering behavior is the redesign of the laboratory
request forms (Mrazek et al. 2020). In our hospital, we peri-
odically revise the request forms. We must ensure that clini-
cians are promptly and adequately informed about those
changes and that the use of the new forms is clearly explained
to them.
In our study, the possibility to link laboratory data with
other health-related databases allowed the integration of mul-
tifaceted information. Analysis of administrative data from the
hospital health information system can be applied to other
laboratory tests.
Limitations of this study
This study was descriptive so we could not assess the
advantages of rapid PCR tests vs. other types of testing
or no test. In addition, we did not know how the manage-
ment of patients hospitalized with respiratory illness was
influenced by the influenza test result and by their time-
liness; nonetheless, the fact that overall consumption of
oseltamivir doses during the influenza season was similar
in 2018–19 and in 2017–18 suggests that the use and
result of the diagnostic tests did not have a substantial
impact on the consumption of antiviral drug at the hospi-
tal level. However, variations in both directions were ob-
served in many wards, which might reflect some influence
of virologic diagnoses on clinical practice.
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